Data layers Raw facts Calculated Model prediction AI interpretation

IPO Timeline Raw facts

Broker Deadline
Morning deadline
HKEX Deadline
Noon deadline
Broker Results (T-2)
Some brokers release in afternoon
Grey Market (T-1)
Afternoon
HKEX Allotment (T-1)
Evening
Registrar Allotment (T-1)
Evening
Listing Day (T)
First day of trading

Company Overview

Stock NameHealthyway Inc
Stock Code02587
Company Full NameHealthyWay Inc.
Industry軟件服務
Principal Activities公司是中國經營數字健康醫療服務平臺。
Listing Date2024-12-30
Listing Rules EraOld Rules
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國福建省福州市鼓樓區軟件大道89號福州軟件園F區3號樓22樓
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttp://www.jkzlkj.cn/
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism To be extracted
Offer PriceHK$ 7.80 / shares
Offer Price RangeFinal offer price only, no range
Lot Size500 shares
Entry ThresholdHK$ 3,900
Par ValueTo be extracted
Offer Period2024-12-18 to 2024-12-23
Global Offering Shares25,000,000 shares
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone Share51.2%
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 195,000,000

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 500 HK$ 3,900
2 lots 1,000 HK$ 7,800
3 lots 1,500 HK$ 11,700
4 lots 2,000 HK$ 15,600
5 lots 2,500 HK$ 19,500
6 lots 3,000 HK$ 23,400
7 lots 3,500 HK$ 27,300
8 lots 4,000 HK$ 31,200
9 lots 4,500 HK$ 35,100
10 lots 5,000 HK$ 39,000
12 lots 6,000 HK$ 46,800
14 lots 7,000 HK$ 54,600
16 lots 8,000 HK$ 62,400
18 lots 9,000 HK$ 70,200
20 lots 10,000 HK$ 78,000
30 lots 15,000 HK$ 117,000
40 lots 20,000 HK$ 156,000
50 lots 25,000 HK$ 195,000
60 lots 30,000 HK$ 234,000
70 lots 35,000 HK$ 273,000
80 lots 40,000 HK$ 312,000
90 lots 45,000 HK$ 351,000
100 lots 50,000 HK$ 390,000
120 lots 60,000 HK$ 468,000
140 lots 70,000 HK$ 546,000
160 lots 80,000 HK$ 624,000
180 lots 90,000 HK$ 702,000
200 lots 100,000 HK$ 780,000
300 lots 150,000 HK$ 1,170,000
400 lots 200,000 HK$ 1,560,000
500 lots 250,000 HK$ 1,950,000
600 lots 300,000 HK$ 2,340,000
700 lots 350,000 HK$ 2,730,000
800 lots 400,000 HK$ 3,120,000
900 lots 450,000 HK$ 3,510,000
1,000 lots 500,000 HK$ 3,900,000
1,200 lots 600,000 HK$ 4,680,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1,400 lots 700,000 HK$ 5,460,000
1,600 lots 800,000 HK$ 6,240,000
2,000 lots 1,000,000 HK$ 7,800,000
2,200 lots 1,100,000 HK$ 8,580,000
2,500 lots 1,250,000 HK$ 9,750,000

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 2.34B
Est. Threshold HK$ 9.71B
Analysis Result HK market cap below threshold, need +314%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceRMB 168.7 million
Listing ExpensesTo be extracted
Listing Expenses / Funds Raised~41.6%
Total Pre-IPO InvestmentTo be extracted
First Day CloseHK$ 10.66
First Day OpenHK$ 9.95
First Day Change36.67%
First Day Volume3281100.0
First Day Turnover32586100.0
Use of Proceeds
1、約33.5%或約40.6百萬港元擬于未來三年用于業務發展,特別是健康醫療服務; 2、約27.0%或約32.7百萬港元擬用于未來三年的業務發展,特別是企業服務及數字營銷服務; 3、約21.0%或約25.4百萬港元擬用作戰略投資或收購; 4、約14.5%或約17.5百萬港元將用作研發; 5、約4.0%或約4.8百萬港元預期將用作營運資金及一般企業用途。

Underwriting Syndicate

Sole Sponsor (1)
建银国际金融有限公司 CE AJO225
Overall Coordinators (2)
建银国际金融有限公司 CE AJO225 SHENWAN HONGYUAN SECURITIES (H.K.) LIMITED CE AAC927
Joint Bookrunners (11)
建银国际金融有限公司 CE AJO225 SHENWAN HONGYUAN SECURITIES (H.K.) LIMITED CE AAC927 BOCI ASIA LIMITED CE AET863 Livermore Holdings Limited CE BJN764 Fosun International Securities Limited CE AAF432 ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855 CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536 Ruibang Securities Limited CE BIJ312 SINOLINK SECURITIES (HONG KONG) COMPANY LIMITED CE AAI195 VICTORY SECURITIES COMPANY LIMITED CE ABN091 富途证券国际(香港)有限公司 CE AZT137
Joint Lead Managers (12)
建银国际金融有限公司 CE AJO225 SHENWAN HONGYUAN SECURITIES (H.K.) LIMITED CE AAC927 BOCI ASIA LIMITED CE AET863 Livermore Holdings Limited CE BJN764 Fosun International Securities Limited CE AAF432 ZHONGTAI INTERNATIONAL SECURITIES LIMITED CE BAA855 CHINA EVERBRIGHT SECURITIES (HK) LIMITED CE AAW536 Ruibang Securities Limited CE BIJ312 SINOLINK SECURITIES (HONG KONG) COMPANY LIMITED CE AAI195 VICTORY SECURITIES COMPANY LIMITED CE ABN091 富途证券国际(香港)有限公司 CE AZT137 PATRONS SECURITIES LIMITED CE BPQ161

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 横琴粤澳深度合作区产业投资基金(有限合伙) 99,894,600 HKD — 51.23% — 6 months 2025-06-30

Directors & Management

PositionChinese nameEnglish Name
Chairman張萬能—
Company Secretary陳宙峰,談俊緯—
No director data available.

Major Shareholders

Major Shareholders & Holdings豐基有限公司(33.71%),百度(香港)有限公司(12.10%),佳滿集團投資有限公司(10.43%),美逸有限公司(9.23%)
AI AI Analysis AI interpretation deepseek-v4-pro · AI-generated
!
Underlying data failed quality checks; AI interpretation downgraded and shown for reference only.

Market Sentiment

健康之路 IPO saw a retail oversubscription of 34.42 times, indicating moderate market enthusiasm. The overall hit rate was 65.96%, meaning about two-thirds of valid applicants received allocations, which is relatively high. The final offer price of HK$7.8 was fixed, with no pricing range to gauge demand intensity. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

A notable tier anomaly exists: the A-tail (applied 500,000 lots) expected only 0.53 lots on average, while the B-head (600,000 lots) expected 1 lot, showing a disproportionate jump in allocation efficiency at the B threshold. This inefficiency means A-tail applicants faced a high chance of receiving zero lots despite a substantial subscription. Broker fee efficiency would vary significantly across tiers, with B-head offering better per-lot allocation. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Demographic breakdown data is unavailable for this IPO, with total holders, mainland China participation, and Hong Kong participation all reported as zero. Without demographic data, it is impossible to assess regional or gender participation patterns. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

About this page

This page shows Healthyway Inc (02587) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect